Tempus, a leader in artificial intelligence and precision medicine, announced that the U.S. Food & Drug Administration (FDA) has granted the company Breakthrough Device...
HebeCell Corp, a biotechnology company developing ProtoNK cell therapeutics based on its proprietary 3D PSC-NK manufacture platform, and Logomix Inc, a Tokyo-based synthetic biology...
The two organizations join forces to develop pioneering AI-based solutions for efficient chemical synthesis planning that accelerates the development of new drugs.
CAS, a division...
Increase the number of employees to guide the direction of the company and promote the growth strategy as a next-generation CDMO.
To continue its momentum...
Fresenius Kabi announced it has introduced Plerixafor Injection, a generic equivalent to Mozobil®, available immediately in the United States in a 24 mg per...
